Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Celiac Disease Treatment Market Expected to Grow Between 2025 And 2029?
The market size for treating celiac disease has seen a steady increase in recent years. There is a projected growth from $0.61 billion in 2024 to $0.66 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 8.8%. Factors contributing to this growth throughout the historic period include the escalating incidence of celiac disease, enhanced awareness and diagnosis, increasing demand for non-diet based treatments, a robust pipeline of innovative therapies, encouraging regulatory strategies, and greater investment by pharmaceutical companies.
In the forthcoming years, the market size for treating celiac disease is projected to witness considerable growth, rising to $0.94 billion by 2029 at a 9.3% Compound Annual Growth Rate (CAGR). This expansion during the projected period could be ascribed to the growing worldwide incidence of celiac disease, heightened awareness and detection rates, ongoing clinical investigations into new treatments, increasing demand for gluten-free substitutes, encouraging legislation for rare diseases, and an uptick in healthcare spending. Major developments anticipated during this period include the implementation of new non-dietary therapies, progression in enzyme supplement technology, personalized treatment strategies, the creation of peptide-based immunotherapies, enhanced diagnostic equipment, and advancements in clinical trials.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
What Are the Core Market Drivers Propelling Growth in the Celiac Disease Treatment Industry?
The growth of the celiac disease treatment market is anticipated to accelerate owing to the increasing number of diabetes cases. Diabetes, a long-lasting health condition, occurs when the body fails to maintain appropriate blood glucose levels. The mutual need for dietary supervision contributes to the increased incidence of diabetes as both diabetes and celiac disease necessitate rigorous monitoring of food consumption to regulate blood sugar levels and avoid potential health risks. Celiac disease treatment plays a significant role in managing diabetes through the promotion of a gluten-free diet, contributing to enhanced digestive health and better absorption of nutrients. It also aids in improved blood sugar management and minimization of complications for individuals dealing with both conditions. For instance, National Health Service, a government department based in the UK, reported that around 3,615,330 individuals registered with a general practitioner (GP) were identified with non-diabetic hyperglycemia or pre-diabetes in 2023, signifying an 18% increase from 3,065,825 instances in 2022. Thus, the increasing incidence of diabetes is fueling the growth of the celiac disease treatment market.
How Is the Celiac Disease Treatment Market Segmented?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp
Which Regions Are Driving the Next Phase of the Celiac Disease Treatment Market Growth?
North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Celiac Disease Treatment Industry?
Leading organizations in the celiac disease treatment market are concentrating on the development of oral therapies, such as small molecule therapies. These therapies are aimed at delivering targeted relief by inhibiting immune reactions to gluten, enhancing patient compliance, and furnishing alternative solutions to stringent gluten-free diets. Small molecule therapies are microscopic drugs that make their way into cells with ease to target and cure proteins or enzymes that cause diseases. For example, in February 2025, Immunic Inc., a US biotech firm, introduced IMU-856. IMU-856 is a small molecule that amplifies the levels of endogenous glucagon-like peptide-1 (GLP-1), thereby improving the intestinal barrier function in patients with celiac disease. It also boosts nutrient absorption and reduces symptoms without impeding immune activity.
View the full report here:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
How Is the Celiac Disease Treatment Market Defined and What Are Its Core Parameters?
Celiac disease treatment involves managing the Celiac disease, an autoimmune reaction to gluten that damages the small intestine and impairs nutrient absorption by following a strict gluten-free diet. It avoids foods and products containing wheat, barley, rye, and other gluten-containing grains. Celiac disease treatment reduces symptoms, heals the lining of the small intestine, and prevents long-term health issues.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24186
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model